Biogen expects to launch IMRALDI in Europe on October 16, 2018
Biogen will be the first company to offer biosimilars of all three major anti-TNF therapies in Europe
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.
Copyright © 2016-2018 Drugdu.com. All Rights Reserved.